Fig. 4From: Clinical symptoms, biochemistry, and liver histology during the native liver period of progressive familial intrahepatic cholestasis type 2Biochemistry in Japanese PFIC2 patients with native liver. Each test result is shown as a ratio to values at the Inti. The median measured during the Mid-period was used for the Mid-values. Data concerning patients without NaPB therapy are shown as means with 95% CI (n = 12). A grey horizontal and dotted line indicates 1.0. Init, the initial visit; End, the last visit (T01 and T02) or the last visit before LDLT (C01–C12); Mid, visits between the initial and the endBack to article page